Pulmonary Hypertension News and Research

RSS
Pulmonary arterial hypertension (PAH) is a condition involving high blood pressure and structural changes in the walls of the pulmonary arteries, which are the blood vessels that connect the right side of the heart to the lungs. Affecting people of all ages and ethnic backgrounds - but most commonly found in young women of child-bearing years - the disease has historically been chronic and incurable, with a poor survival rate. PAH is often not diagnosed in a timely manner because its early symptoms can be confused with those of many other pulmonary and respiratory conditions. Symptoms include shortness of breath, extreme fatigue, dizziness, fainting, swollen ankles and legs and chest pain (especially during physical activity). With proper diagnosis, there are currently several therapies to alleviate symptoms and improve quality of life for PAH patients. The key is to find a PAH specialist and pursue immediate treatment.
Editorial emphasizes the critical role of heart-lung interactions in pulmonary vascular disease

Editorial emphasizes the critical role of heart-lung interactions in pulmonary vascular disease

AI-powered ECG model outperforms doctors in detecting hidden heart disease

AI-powered ECG model outperforms doctors in detecting hidden heart disease

Breakthrough soft robotics could redefine artificial heart technology

Breakthrough soft robotics could redefine artificial heart technology

New screening tool enhances early detection of pulmonary hypertension

New screening tool enhances early detection of pulmonary hypertension

Study finds higher rates of pulmonary embolism in pediatric patients

Study finds higher rates of pulmonary embolism in pediatric patients

Hidden heart and lung damage detected in patients with long COVID

Hidden heart and lung damage detected in patients with long COVID

Redefining cardiovascular medicine through the lens of sncRNAs

Redefining cardiovascular medicine through the lens of sncRNAs

Promising findings for the treatment of patients with pulmonary arterial hypertension with a high risk of mortality

Promising findings for the treatment of patients with pulmonary arterial hypertension with a high risk of mortality

Study highlights pulmonary artery denervation as a key intervention for pulmonary hypertension

Study highlights pulmonary artery denervation as a key intervention for pulmonary hypertension

Microphysiological systems in drug discovery

Microphysiological systems in drug discovery

Researchers create an atlas of health associations for GLP-1 receptor agonists

Researchers create an atlas of health associations for GLP-1 receptor agonists

electronRx to launch purpleDx pulmonary disease smartphone app for remote lung function monitoring

electronRx to launch purpleDx pulmonary disease smartphone app for remote lung function monitoring

Vitamin D receptor activation slows cell overgrowth in pulmonary hypertension

Vitamin D receptor activation slows cell overgrowth in pulmonary hypertension

Mountaineering mice offer insight into evolutionary adaptation to localized conditions

Mountaineering mice offer insight into evolutionary adaptation to localized conditions

MMRI professor receives $3.7 million NIH grant to support research on pulmonary embolism

MMRI professor receives $3.7 million NIH grant to support research on pulmonary embolism

Understanding the role of TIPS in improving renal function amid cirrhosis

Understanding the role of TIPS in improving renal function amid cirrhosis

New guidelines for cardiovascular management in noncardiac surgery released

New guidelines for cardiovascular management in noncardiac surgery released

Coordinated health teams may help improve outcomes for children with Trisomy 21 and heart conditions

Coordinated health teams may help improve outcomes for children with Trisomy 21 and heart conditions

Protein encoded by the ASPN gene plays a protective role in pulmonary arterial hypertension

Protein encoded by the ASPN gene plays a protective role in pulmonary arterial hypertension

First-ever successful use of modified double-decker technique for scimitar syndrome in a child

First-ever successful use of modified double-decker technique for scimitar syndrome in a child

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.